Mahwah, New Jersey-based Glenmark Pharmaceuticals Inc., USA, has recalled 114 batches of its Potassium Chloride Extended-Release Capsules, USP (750 mg) 10 mEq K, because of the product’s failure to dissolve, reports the FDA. Initiated by Glenmark on June 24, 2024, the voluntary, consumer-level recall covers […]
Jun 27, 2024
By TruLaw